About Hyundai Bioland
Cosmetic lab Hyundai Bioland operates state-of-the-art facilities in Cheongju, South Korea, specializing in natural ingredients extraction and biotechnology. With manufacturing centers across Osong, Ansan, and Ochang, the company delivers:
- 7,600 tons annual cosmetic production
- 630 tons of health food supplements
- 2 million medical device units
- Research in regenerative medicine and biomaterials
Backed by FDA, ISO, and GMP certifications, Hyundai Bioland’s 1,000+ natural material library supports innovation across South Korea and its Xiamen, China facility.
Frequently asked questions
Hyundai Bioland operates in three main product categories:
- Cosmetic ingredients
- Production capacity: 7,600 tons annually
- Natural material extraction
- Fermentation-derived ingredients
- Health supplements
- Production capacity: 630 tons annually
- Food-grade ingredients
- Nutritional compounds
- Medical materials
- Production capacity: 2 million units annually
- Biomaterials
- Tissue regeneration products
The company processes these materials through extraction, fermentation, and purification methods.
Hyundai Bioland employs the following technologies and holds multiple certifications:
- Core Technologies
- Extraction processes
- Fermentation methods
- Purification systems
- Tissue regeneration
- Quality Certifications
- EFFCI GMP
- API-GMP
- ISO 9001
- ISO 14001
- ISO 13485
- CE certification
- FDA certification
Research institutes focus on:
- Life sciences
- Bio-convergence
- Regenerative medicine
Hyundai Bioland operates four manufacturing facilities:
| Location | Production Focus |
|---|---|
| Osong, Korea | Cosmetics and pharmaceutical ingredients |
| Ansan, Korea | Health food products |
| Ochang, Korea | Medical devices |
| Xiamen, China | International production facility |
Each facility maintains international manufacturing standards and certifications.
More details about Hyundai Bioland
A leading biotech company in South Korea
Established in 1995, Hyundai Bioland has grown into a major player in the biotechnology sector, with an annual revenue reaching 99.15 billion KRW. The company operates as a cosmetic lab and research facility, focusing on natural ingredients processing and development.
Advanced manufacturing capabilities
The company maintains significant production capacity across various sectors:
- 7,600 tons of cosmetic products
- 630 tons of food-related items
- 2 million units of medical devices
Strategic facility locations
Hyundai Bioland operates multiple specialized facilities across South Korea:
- Osong facility: Focuses on cosmetics and pharmaceutical production
- Ansan facility: Specializes in health food manufacturing
- Ochang facility: Dedicated to medical device production
The company has also expanded internationally with a facility in Xiamen, China, strengthening its presence in the Asian market.
Research and development excellence
Technology focus areas
The company excels in several biotechnology domains:
- Material extraction and fermentation processes
- Biomaterial processing techniques
- Tissue regeneration research
- Natural ingredient development
Research infrastructure
The company maintains dedicated research institutes for:
- Life sciences advancement
- Bio-convergence studies
- Regenerative medicine development
Quality assurance and certifications
Hyundai Bioland maintains high quality standards through multiple international certifications:
- EFFCI certification
- API-GMP compliance
- ISO certifications (9001, 14001, 13485)
- CE marking
- FDA certification
Company gallery
